An increasing number of studies indicate that RTP4 can serve as one of the important markers of diagnosis or prognosis of various diseases, such as cutaneous melanoma, breast cancer, type 2 diabetes and viral infection [18,32,33,34]. This evidence concerns the gene RTP4 and breast cancer.